Table 2.
Data sources (18+).
| WHO Region ˆ | AFRO | AMRO | SEARO | SEARO | SEARO | EURO | WRPO |
|---|---|---|---|---|---|---|---|
| Dataset name (Country of origin) | Cameroon | Guatemala | India | Maldives | Nepal | Turkey | Vanuatu |
| Place, date | Fundong Health District (North West), 2013 | National, 2016 | Mahbubnagar District, Telengana State, 2014 | National, 2017 | Tanahun District, 2016 | Sultanbeyli district Istanbul, Turkey 2019 | SANMA and TORBA province, 2019 |
| Sampling Strategy | Two stage Cluster Sampling, Clusters of 80 ‡ | Two stage Cluster Sampling, Clusters of 50 ‡ | Two stage Cluster Sampling, Clusters of 80 ‡ | Two stage Cluster Sampling, Clusters of 125 ‡ | Two stage Cluster Sampling, Clusters of 200 ‡ | Syrian refugees only: 80 clusters of 50 people selected from the municipality refugee database with probability proportionate to size | Full population census |
| WG modules | ESF | ESF | ESF | SS-E | SS-E | SS-E | LFS-DM Anxiety and depression questions only asked if self-report, not proxy |
| WG respondent | Self unless unable to communicate, no proxy if unavailable | Self unless unable to communicate or if unavailable after 2 visits | Self unless unable to communicate, no proxy if unavailable | Self unless unable to communicate or if unavailable after 3 or more attempts | Self unless unable to communicate or if unavailable after 3 or more attempts | Self unless unable to communicate, no proxy if unavailable | Self unless unable to communicate or if unavailable (after 2 attempts where feasible) |
| % WG completed by proxy | 0 | 8.5% | 0 | 36.8% | 6.4% | 0 | 24.7% |
| Assistive products | Use of glasses, hearing aids and mobility products reported separately | Use of glasses, hearing aids and mobility products reported separately | Use of glasses, hearing aids and mobility products reported separately | Use of glasses, hearing aids and mobility products reported separately | Use of glasses, hearing aids and mobility products reported separately | Use of glasses and hearing aids reported separately | Included within vision and hearing question |
| Total Sample (response rate%) | 3567 (87%) | 13,073 (88%) | 3574 (88%) | 5362 (82%) | 5692 (95%) | 3084 (77%) | 56,402 (85%) |
| Sub-sample size (complete data%) | 1617 (96%) | 8910 (85%) | 2350 (99%) | 3592 (100%) | 4067 (100%) | 1554 (99.7%) | 31,362 (100%) |
| Average age (years), range | 44.5 (18–99) | 38.7 (18–100) | 39.2 (18–98) | 39.4 (18–102) | 43.0 (18–96) | 34.8 (18–90) | 37.7 (18–115) |
| % Female | 70%† | 54% | 54% | 58.0%† | 57.7% | 56.3% | 49% |
ˆ WHO Regional Abbreviations: Africa (AFRO), Americas (AMRO), Eastern Mediterranean (EMRO), Europe (EURO), South-East Asia (SEARO), Western Pacific (WPRO) ‡ In each case, this included selection of enumeration areas (clusters) from most recent Census with Probability Proportionate to Size (PPS), followed by modified Compact Segment Sampling (CSS) within clusters until pre-determined number of participants per cluster enumerated without replacement. †Sample substantially different to census, age-sex adjusted estimates presented.